From my quick glance it appears to be the outlook..
Market research (IBIS) points to 3.5% revenue growth in the receivables management sector in 2015-2020, which is above forecast GDP growth, but lower than industry growth in the prior five years.
For the current financial year we do not expect to deliver the same level of earnings growth as averaged over the past five years, and given the deterioration in consumer and business conditions over the past quarter may continue, we estimate that NPAT for FY16 will be approximately $23.5 million.
- Forums
- ASX - By Stock
- CLH
- Ann: Chairman's Address and MD/CEO's Presentation to AGM
Ann: Chairman's Address and MD/CEO's Presentation to AGM, page-3
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CLH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online